title: The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
abstract: X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder biochemically characterized by the accumulation of very long chain fatty acids (VLCFA), particularly hexacosanoic acid (C(26:0)) and tetracosanoic acid (C(24:0)), in tissues and biological fluids. Although patients affected by this disorder predominantly present central and peripheral demyelination as well as adrenal insufficiency, the mechanisms underlying the brain damage in X-ALD are poorly known. The current treatment of X-ALD with glyceroltrioleate (C(18:1))/glyceroltrierucate (C(22:1)) (Lorenzo's oil, LO) combined with a VLCFA-poor diet normalizes VLCFA concentrations, but the neurological symptoms persist or even progress in symptomatic patients. Considering that free radical generation is involved in various neurodegenerative disorders and that in a previous study we showed evidence that oxidative stress is probably involved in the pathophysiology of X-ALD symptomatic patients, in the present study we evaluated various oxidative stress parameters, namely thiobarbituric acid reactive species (TBA-RS) and total antioxidant reactivity (TAR) in plasma, as well as the activities of the antioxidant enzymes catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) in erythrocytes from symptomatic and asymptomatic X-ALD patients and verified whether LO treatment and a VLCFA restricted diet could change these parameters. We observed a significant increase of plasma TBA-RS in symptomatic and asymptomatic X-ALD patients, reflecting induction of lipid peroxidation even before the disease was manifested. In addition, LO treatment did not alter this profile. Furthermore, plasma TAR measurement of X-ALD patients was not different from that of controls. Similarly, the antioxidant enzyme activities CAT, SOD and GPx were not altered in erythrocyte from X-ALD patients as compared to controls. We also examined the in vitro effects of hexacosanoic acid (C(26:0)) and tetracosanoic acid (C(24:0)) alone or combined with oleic (C(18:1))/erucic (C(22:1)) acids on various oxidative stress parameters in cerebral cortex of young rats, namely chemiluminescence, TBA-RS, TAR, CAT, SOD and GPx in order to investigate whether those fatty acids were able to induce oxidative stress. We found that there was a significant increase of TBARS and of chemiluminescence in rat cerebral cortex exposed to C(26:0)/C(24:0), and that the addition of C(18:1)and C(22:1) to the assays did not prevent this effect. Furthermore, TAR measurement was not altered by C(26:0) and C(24:0) acids in rat cerebral cortex. Taken together, our results indicate that lipid peroxidation occurs in X-ALD and that LO treatment does not attenuate or prevent free radical generation in these patients. Therefore, it may be presumed that antioxidants should be considered as an adjuvant therapy for X-ALD patients.
authors.affiliation: Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil. marion_deon@yahoo.com.br
authors.forename: Marion
authors.initials: M
authors.lastname: Deon
authors.forename: Moacir
authors.initials: M
authors.lastname: Wajner
authors.forename: Lisana R
authors.initials: LR
authors.lastname: Sirtori
authors.forename: Douglas
authors.initials: D
authors.lastname: Fitarelli
authors.forename: Daniella M
authors.initials: DM
authors.lastname: Coelho
authors.forename: Angela
authors.initials: A
authors.lastname: Sitta
authors.forename: Alethéa G
authors.initials: AG
authors.lastname: Barschak
authors.forename: Gustavo C
authors.initials: GC
authors.lastname: Ferreira
authors.forename: Alexsandro
authors.initials: A
authors.lastname: Haeser
authors.forename: Roberto
authors.initials: R
authors.lastname: Giugliani
authors.forename: Carmen R
authors.initials: CR
authors.lastname: Vargas
mesh_terms: D000326:Adrenoleukodystrophy / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D000704:Analysis of Variance; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D002648:Child; D004338:Drug Combinations; D004883:Erucic Acids / Q000494:pharmacology*; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D013482:Superoxide Dismutase / Q000378:metabolism; D017392:Thiobarbituric Acid Reactive Substances / Q000032:analysis; D014304:Triolein / Q000494:pharmacology*
chemical_list: D004338:Drug Combinations; D004883:Erucic Acids; D005231:Fatty Acids, Unsaturated; C079420:Lorenzo's oil; D017392:Thiobarbituric Acid Reactive Substances; D014304:Triolein; D013482:Superoxide Dismutase